Why Targeting HDL Should Work as a Therapeutic Tool, but Has Not

Journal of Cardiovascular Pharmacology - United States
doi 10.1097/fjc.0b013e31829d48a5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search